FLUZONE Quadrivalent
FLUZONE® Quadrivalent [Influenza Virus Vaccine Quadrivalent Types A and B (Split Virion)] for intramuscular use, is a sterile suspension containing four strains of influenza viruses propagated in embryonated chicken eggs, inactivated with formaldehyde, concentrated and
Download FLUZONE Quadrivalent
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
PRESCRIBING INFORMATION CYANOCOBALAMIN INJECTION, …
pdf.hres.caSupplied: Each ml contains: Cyanocobalamin 1,000 mcg, Sodium Acetate 0.5 mg, Glacial Acetic Acid 0.1 mg, Sodium Chloride 9.0 mg with Benzyl Alcohol 1.5 % as preservative in Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid may have been used to adjust pH . Multiple dose vials of 10 ml and 30mL.
FLUZONE High-Dose Quadrivalent
pdf.hres.casodium chloride solution. - traces of formaldehyde and ovalbumin. ... Quadrivalent does not contain latex (natural rubber). ... (Split Virion)] is a sterile aqueous suspension of inactivated influenza virus for intramuscular injection.
PRODUCT MONOGRAPH
pdf.hres.caPRODUCT MONOGRAPH Pr WELLBUTRIN ... incidence in clinical trials with doses of 450 mg/day was approximately 0.39% (2 of 537 subjects). There were no seizures in clinical trials where subjects (n=1638) were treated up to the maximum recommended dose of 300 mg/day. In post marketing data however, seizures have been observed across all doses and
PRODUCT MONOGRAPH
pdf.hres.caPRODUCT MONOGRAPH DUKORAL® Oral, Inactivated Cholera and ETEC Diarrhea Vaccine Oral Suspension Active Immunizing Agent for the Prevention of Diarrhea Caused by Vibrio cholerae and/or heat-labile toxin producing Enterotoxigenic Escherichia coli ATC Code: J07AE01 Manufactured by: Date of Approval: Valneva Sweden AB,
PRODUCT MONOGRAPH INCLUDING PATIENT …
pdf.hres.caAFLURIA® TETRA (Inactivated Influenza Vaccine (Split Virion)) Product Monograph Page 1 of 24 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION AFLURIA® TETRA Quadrivalent Inactivated Influenza Vaccine (Split Virion) Suspension for Injection Active Immunizing Agent for the Prevention of Influenza ATC Code: J07BB02 2020 - 2021 Strains:
Information, Product, Patients, Monographs, Medication, Including, Product monograph, Product monograph including patient, Product monograph including patient medication information
PRODUCT MONOGRAPH
pdf.hres.ca8.4 Post Market Adverse Reactions Table updated to as per the ... is a biosimilar biologic drug (biosimilar) to HERCEPTIN®. PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS Indications have been granted on the basis of similarity between OGIVRI and the reference biologic drug ... OGIVRI (trastuzumab) can result in the development of ...
doses of 0.3 mL) Active Immunizing Agent Mainz, Rhineland ...
pdf.hres.cacomirnaty (covid-19 vaccine, mrna) product monograph page 2 of 53 recent major label changes 1. indications 11/2021 4. dosage and administration 11/2021 7. warnings and precautions 11/2021 table of contents
PRODUCT MONOGRAPH GRAVOL
pdf.hres.caEar/Nose/Throat Dimenhydrinate may mask the presence of underlying organic abnormalities or the toxic effects of certain antibiotics and other drugs, particularly those drugs causing ototoxicity. Endocrine and Metabolism Use with caution in patients who are poor CYP2D6 metabolizers and in patients with thyroid dysfunction. Gastrointestinal
ENGERIX-B
pdf.hres.caPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION ENGERIX-B Hepatitis B vaccine (recombinant) 0.5 mL and 1.0 mL suspensions of 20 mcg/mL hepatitis B surface antigen for injection Active immunizing agent against infection caused by all known subtypes of hepatitis B virus ATC Code: J07BC01 GlaxoSmithKline Inc. 7333 Mississauga Road
Information, Product, Patients, Monographs, Medication, Including, Engerix, Product monograph including patient medication information engerix
FLULAVAL TETRA (2021-2022)
pdf.hres.caEgg proteins, sodium deoxycholate, ethanol, formaldehyde, sucrose, -tocopheryl hydrogen succinate, polysorbate 80. Thimerosal preservative in the multidose presentation only. For a complete listing see Dosage Forms, Composition and Packaging section. *The prefilled syringe presentation is not available for the 2021- 2 season DESCRIPTION
Related documents
2021/22 Seasonal Influenza Vaccine Eligibility
www.bccdc.caCommunicable Disease Control Manual October 2021 Chapter 2: Immunization Part 4 - Biological Products 1 2021/22 Seasonal Influenza Vaccine Eligibility
VACCINES FOR CHILDREN (VFC) IMMUNIZATION SERVICE …
oeps.wv.gov90686 Influenza virus vaccine, quadrivalent, split virus, preservative free, 0.5 ml dosage, for intramuscular use 90696 Diphtheria, tetanus toxoids, acellular pertussis vaccine and poliovirus vaccine, inactivated (DTaP-IPV), when administered to children 4 years through 6 years of age, for intramuscular use.
Vaccine Excipient Summary
www.cdc.govQuadrivalent (c) 10/2021 Madin Darby Canine Kidney (MDCK) cell protein, phosphate buffered saline, protein other than HA, MDCK cell DNA, polysorbate 80, cetyltrimethlyammonium bromide, and β-propiolactone, thimerosal (multi-dose vials) Influenza (Flulaval) Quadrivalent (c)
Latex in Vaccine Packaging
www.cdc.govAppendix B Appendix B-11 B Appendix B_Web.indd 11 11/1/2021 10:27:00 AM Latex in Vaccine Packaging “Immediate-type allergic reactions due to latex allergy have been described after vaccination, but such reactions
Quarterly Influenza Virus Vaccine Code Update - July 2020
www.cms.govJan 31, 2020 · Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use) is payable by Medicare. This new code will be included on the 2020 Medicare Physician Fee Schedule Database file update and the annual HCPCS update. MACs use the Centers for Medicare & Medicaid Services (CMS)
Services, Center, Medicare, Medicaid, Centers for medicare amp medicaid services, Quadrivalent
Many vaccine information statements are Vacuna ...
www.immunize.orgTitle: Vaccine Information Statement: Serogroup A, C, W, Y Meningococcal Vaccines (MenACWY and MPSV4): What you need to know Author: CDC/NCIRD Subject